• 1.
    Ohnishi M, Ruhno J, Bienenstock J, Milner R, Dolovich J, Denburg J. Human nasal polyp epithelial basophil/mast cell and eosinophil colony-stimulating activity: the effect is T-cell dependent. Am Rev Respir Dis 1988; 138:560564.
  • 2.
    Stoop AE, Hameleers DMH, van Run PEM, Biewenga J, van der Baan S. Lymphocytes and nonlymphoid cells in the nasal mucosa of patients with nasal polyps and of healthy subjects. J Allergy Clin Immunol 1989; 84:734741.
  • 3.
    Gleich GJ, Flavahan NA, Jujisawa T, Wanhoutte PM. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hypersensitivity. J Allergy Clin Immunol 1988; 81:776781.
  • 4.
    Warringa RA, Koenderman JL, Kok PTM, Kreukniet J, Bruijnzeel PLB. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood 1991; 77:26942700.
  • 5.
    Springer TA. Traffic signals for lymphocyte recirculation and leukocyte migration: the multistep paradigm. Cell 1994; 76:301314.
  • 6.
    Rothenberg ME. Eotaxin: an essential mediator of eosinophil trafficking into mucosal tissues. Am J Respir Cell Mol Biol 1999; 21:291295.
  • 7.
    Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992; 12:1746.
  • 8.
    Choe H, Farzan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85:11351148.
  • 9.
    Rot A, Krieger M, Brunnr T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992; 176:14891495.
  • 10.
    Elsner J, Hochstetter R, Kimming D, Kapp A. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol 1996; 26:19191925.
  • 11.
    Graziano FM, Cook EB, Stahl JL. Cytokines, chemokines, RANTES, and eotaxin. Allergy Asthma Proc 1999; 20:141146.
  • 12.
    Bentley AM, Durham SR, Robinson DS, et al. Expression of endothelial and leukocyte adhesion molecules intercellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J Allergy Clin Immunol 1993; 92:857868.
  • 13.
    Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines: effect of chemokine RANTES. J Immunol 1994; 153:21532160.
  • 14.
    Davisson A, Danielsen A, Viale G, et al. Positive identification in situ of mRNA expression of IL-6, and IL-12, and the chemotactic cytokine RANTES in patients with chronic sinusitis and polyposis disease: clinical relevance and relation to allergy. Acta Otolaryngol (Stockh) 1996; 116:604610.
  • 15.
    Allen JS, Elsma R, LaFreniere D, Leonard G, Kreutzer D. Characterization of the eosinophil chemokine RANTES in nasal polyps. Ann Otol Rhinol Laryngol 1998; 107:416420.
  • 16.
    Bartels J, Maune S, Meyer JE, et al. Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES andMCP-3 expression. Rhinolaryngology 1997; 35:171174.
  • 17.
    Terada N, Maesako K, Hamano N, et al. Eosinophil adhesion regulates RANTES production in nasal epithelial cells. J Immunol 1997; 158:54645470.
  • 18.
    Jose PJ, Griffiths-Johnson DA, Collins PD, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airway inflammation. J Exp Med 1994; 179:881887.
  • 19.
    Minshall EM, Cameron L, Lavigne F, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997; 17:683690.
  • 20.
    Elsner J, Höchstetter R, Kimmig D, Kapp A. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol 1996; 26:19191925.